Hematologic malignancies rapidly increasing and unaddressed in Sub-Saharan Africa

April 4, 2012 By Ellen de Graffenreid
Hematologic malignancies rapidly increasing and unaddressed in sub-Saharan Africa
The cancer clinic at UNC Project in Lilongwe, Malawi.

(Medical Xpress) -- Sub-Saharan Africa is experiencing a growing cancer burden, and hematologic malignancies account for almost 10 percent of cancer deaths in the region.  In the United States and other resource-rich settings, patients with diseases such as non-Hodgkin lymphoma, Hodgkin lymphoma, leukemia and multiple myeloma have benefited from treatment advances that have resulted in unprecedented rates of long-term control.

A study pre-published on-line in the March 28, 2012 issue of the journal Blood, argues that these diseases can be effectively treated in a resource-limited setting and offers a clinical service and research agenda to address the growing impact of hematologic malignancies in sub-Saharan Africa.

UNC hematology/oncology and infectious disease fellow Satish Gopal, MD, MPH, is corresponding author on the study.  He notes, “Aging, social and behavioral trends, HIV, and other endemic infections are all contributing to a rapidly increasing cancer burden in sub-Saharan Africa which has the potential to overwhelm fragmented and under-resourced health systems in this part of the world.”

has few resources to diagnose, treat and provide supportive and palliative care to patients with . What is more, available services are concentrated in major population centers in more economically advanced countries, while 63 percent of the population lives in rural areas.  The research team notes critical shortages in the availability of pathologists with expertise in these diseases, an 82 percent deficit in radiotherapy facilities (with 21 countries in the region having no operational units), limited supportive care, and extremely limited facilities for bone marrow and stem cell transplantation.  In addition, chemotherapy availability is highly restricted and cancer medicines can be difficult to administer due to the need for specialized facilities and trained personnel. Global shortages of many generic chemotherapy drugs are further challenging the region’s ability to treat cancer effectively.

Other challenges in the care of these patients include a high endemic infectious burden, as many antibacterial and antifungal drugs commonly used in developed regions are simply unavailable to support patients who are immunosuppressed from cancer treatment, HIV, malnutrition, and other factors.  The region also lacks a blood transfusion infrastructure including lack of centralized national systems for blood collection and banking.  Finally, pain management drugs are often highly-regulated or unavailable.

The research team suggests that strategies can be developed for addressing these issues, including development of conventional and new diagnostics adapted to low-resource settings, making cancer medicines affordable and integrating newer treatments, using the care and research infrastructure established to deal with HIV and other infectious diseases to study and control cancer, increasing global funding for cancer while rigorously assessing cost-effectiveness of control measures, and addressing critical health worker shortages by focusing on training efforts.

Explore further: Anti-HIV vaginal gel promising protection in Africa, SE asia

Related Stories

Anti-HIV vaginal gel promising protection in Africa, SE asia

April 20, 2011
A new vaginal microbicide gel and drug formulation looks promising for empowering women in developing countries to protect themselves from HIV during intercourse, without having to inform their partners, according to research ...

Scientists find new drug target for hard-to-treat leukaemia

March 30, 2012
(Medical Xpress) -- Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival, according to research ...

Study finds hospitals of last resort deliver lower quality of lung cancer care

September 9, 2011
A new study finds that lung cancer patients treated in hospitals that care for a high percentage of uninsured and Medicaid-insured patients, so-called "high safety-net burden facilities," were significantly less likely to ...

Earlier antiretroviral therapy might reduce the burden of cancer in those with HIV

November 22, 2011
HIV-infected patients are at increased risk for cancer as a result of both their impaired immune system and lifestyle factors, such as smoking, according to researchers at Kaiser Permanente.

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.